|
Trolamine
|
DB13747 |
[Trolamine, which is also referred to as triethanolamine (TEA), is a tertiary amine and a triol. It is a bifunctional compound that exhibits both properties of alcohols and amines. Trolamine contains small amounts of diethanolamine and ethanolamine and may also act as an antioxidant against the auto-oxidation of animal and vegetable fats [A27174]. It is commonly used as a pH adjuster and surfactant in industrial and cosmetic products such as skin and hair conditioning products.] |
|
VTP-27999
|
DB12416 |
[VTP-27999 has been used in trials studying the basic science of Renal Function.] |
|
Tidiacic arginine
|
DB13748 |
|
|
Anagliptin
|
DB12417 |
[Anagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.] |
|
Sabarubicin
|
DB12410 |
[Sabarubicin has been used in trials studying the treatment of Prostate Cancer, Testicular Germ Cell Tumor, and Unspecified Adult Solid Tumor, Protocol Specific.] |
|
Ioglycamic acid
|
DB13741 |
|
|
R-428
|
DB12411 |
[BGB324 has been investigated for the treatment of Non-Small Cell Lung Cancer.] |
|
Elcatonin
|
DB13742 |
|
|
Sodium aurotiosulfate
|
DB13743 |
|
|
Gemigliptin
|
DB12412 |
[Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.] |
|
Indusatumab vedotin
|
DB12413 |
[Indusatumab vedotin has been used in trials studying the treatment of Pancreatic Adenocarcinoma, Adenocarcinoma of the Stomach, Recurrent Gastric Adenocarcinoma, Metastatic Gastric Adenocarcinoma, and Advanced Gastrointestinal Carcinoma, among others.] |
|
Piromidic acid
|
DB13744 |
|
|
Bemegride
|
DB13740 |
[Bemegride is a CNS stimulant that is used to induce convulsions in experimental animals. It has also been used as a respiratory stimulant and in the treatment of barbiturate overdose.] |
|
Cerivastatin
|
DB00439 |
[On August 8, 2001 the U.S. Food and Drug Administration (FDA) announced that Bayer Pharmaceutical Division voluntarily withdrew Baycol from the U.S. market, due to reports of fatal Rhabdomyolysis, a severe adverse reaction from this cholesterol-lowering (lipid-lowering) product. It has also been withdrawn from the Canadian market.] |
|
Bendroflumethiazide
|
DB00436 |
[A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)] |
|
Hemi-Babim
|
DB01767 |
|
|
Beta-(2-Naphthyl)-Alanine
|
DB01766 |
|
|
Nitric Oxide
|
DB00435 |
[Nitric oxide or Nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals including humans and is an extremely important intermediate in the chemical industry. It is also a toxic air pollutant produced by automobile engines and power plants.
Nitric oxide (NO) should not be confused with nitrous oxide (N2O), a general anaesthetic, or with nitrogen dioxide (NO2) which is another poisonous air pollutant.
The nitric oxide molecule is a free radical, which is relevant to understanding its high reactivity. It reacts with the ozone in air to form nitrogen dioxide, signalled by the appearance of the reddish-brown color.] |
|
Ceftazidime
|
DB00438 |
[Semisynthetic, broad-spectrum antibacterial derived from cephaloridine and used especially for Pseudomonas and other gram-negative infections in debilitated patients.] |
|
Allopurinol
|
DB00437 |
[Gout is a disease that occurs by the deposition of monosodium urate crystals (MSU) in body tissues, especially around joints [A175942]. This disease has been well-documented in historical medical records and appears in the biographies of several prominent, historically recognized individuals [A175942].
Allopurinol is a xanthine oxidase enzyme inhibitor that is considered to be one of the most effective drugs used to decrease urate levels and is frequently used in the treatment of chronic gout [A36705]. It was initially approved by the FDA in 1966 [L5674] and is now formulated by several manufacturers [L5677].] |
